Top Banner
Microencapsulation In Microgravity Co-Principle Investigators: M. McMillen, C. Murray Co-Investigators: J. Faust, M. Joyce Collaborators: A. Gulrajani, C. McGrath, C. Padilla, S. Zouras

Microencapsulation In Microgravity

Feb 24, 2016




Microencapsulation In Microgravity. Co-Principle Investigators : M. McMillen , C. Murray Co-Investigators : J. Faust, M. Joyce Collaborators: A. Gulrajani , C. McGrath, C. Padilla, S. Zouras. What is Microencapsulation?. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.

Microencapsulation in Microgravity

Microencapsulation In MicrogravityCo-Principle Investigators: M. McMillen, C. MurrayCo-Investigators: J. Faust, M. JoyceCollaborators: A. Gulrajani, C. McGrath, C. Padilla, S. Zouras1 What is Microencapsulation?

Microencapsulation, or the inactive coating used in many drugs such as Aleve, ensures the controlled release of medication.

Our experiment tested how microgravity affects the release of the microencapsulated medicine Aleve. Comparing the concentration of dissolved Naproxen in space and on Earth determined the strength of microencapsulation in microgravity. The effectiveness of microencapsulated medicine in microgravity is important to analyze, for it can prevent uncontrolled release of medicine in astronauts as well as lead to further research on microencapsulated medicine.

MaterialsVolume 3: 0.3 mL of the antacid Mylanta. This neutralizes the simulated stomach acid and stops the reaction.Volume 2:2.5 mL of our simulated Stomach acid solution. It has a molarity of 0.3 M. It dissolves the Aleve in space.Volume 1: 20mg of Aleve. The active ingredient, Naproxen, is microencapsulated. The simulated stomach acid will dissolve the Aleve. Aleve Experiment Timeline Deactivation Date: 2 days after, 1/15/14 at 9:30 am second clamp is released and antacid neutralizes the solution to stop reactionActivation Date: 1/13/14 at 7:40 AM First clamp was taken out and Aleve was combined with the simulated stomach acid.

What is Thin Layer Chromatography?Thin Layer Chromatography (TLC) is the process by which components in a solution are separated using a solvent. Isopropanol was used to carry the naproxen in the Aleve up the strip. The naproxen travels up the strip via capillary action.The intensity of the dot of the solution after the experiment is run, reveals the concentration of the solution.

Analyzing the Data

To analyze the Data, we took pictures of the TLC strips. We then analyzed them using a program called Image J, a Java image processing and analysis program from the NIH. We loaded the picture into Image J, subtracted the background color, and plotted the intensity of the dots. The peaks were then cut out and weighed. Results

We graphed the weight of the peaks vs. the amount of naproxen in each spot to find a standard curve. We ran 7 tests.

We then derived a linear equation and found the approximate amount of Naproxen (g) dissolved in the ground and space tests. ConclusionSpaceGround23.63733.48516.26619.25513.68410.7125.47812.89224.27517.13626.7416.94Average21.67318.403T Test.193 80.8% certaintyStandard Deviation5.3728.018The microcapsule dissolves faster in space than on Earth, for more micrograms of Naproxen were dissolved in the space test. Microencapsulation in space is less effective, for it had a higher dissolution of Naproxen in the time span, therefore making its release less controlled. There is an 80.8% certainty that the relationship between these points is true. AcknowledgementsPartner InstitutionsDowningtown STEM AcademyDowningtown Area School District

West Pharmaceutical Services, Inc.Bentley SystemsSubaru of America, Inc.NASA Pennsylvania Space Grant ConsortiumLitts Quality Technologies (LQT)Analytical Graphocs Inc. (AGI)Center for the Advancement of Science in SpaceNational Center for Earth and Space ScienceTrans Lunar DesignsAbsolutDataThe SI OrganizationMorphotek